Scalable ADCF Virus Production Using HyClone™ VaccineXpress Med…
January 16, 2020 - GE Healthcare Life Sciences In this study, HyClone VaccineXpress cell culture medium was used for the propagation of influenza virus and rotavirus in an animal-derived component-free (ADCF) p…

2019’s Top Bioprocessing Trends and What to Expect in 2020
January 16, 2020 - Bioprocess Development Forum 2019 proved to be an exciting year for biopharmaceutical developers and process engineers, filled with both advancements and lessons. Considering how far the indus…

Risk Assessment: Studying Chromatography Resin Variability
December 16, 2019 - GE Healthcare Life Sciences Many factors can give rise to process variability, such as variation in different process parameters or raw materials. This article focuses on process robustness and…

A Continuous Confidence Boost
December 16, 2019 - GE Healthcare Life Sciences Continuous processing of monoclonal antibodies (mAb) could offer a number of advantages, but regulatory uncertainty and upfront investment remain sticking points. …

The Evolving Role of Starting Materials in Cell and Gene Therapy
December 16, 2019 - BioPharm International The Evolving Role of Starting Materials in Cell and Gene Therapy Accelerated approval pathways and growing demand for cell and gene therapies are putting pressure …

Factors Which Impact mAb Process Scale-Up
December 16, 2019 - GE Healthcare Life Sciences <iframe width="560" height="315" src="https://www.youtube.com/embed/uY-MrojSP5A" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; pictur…

Raw Material Variability: The Need for Deeper Process Understandi…
December 5, 2019 - GE Healthcare Life Sciences Principles and methodologies for biopharmaceutical development and manufacturing are well established today. However, the increased molecular diversity and drive f…

Process Development and Optimization Using the ReadyToProcess WAV…
December 5, 2019 - GE Healthcare Life Sciences Download this application note to learn about the technical feasibility of the Method editor and operations in dual mode (where two parallel cultures are controlle…

New Therapies Present Scaling Challenges
December 5, 2019 - BioPharm International New Therapies Present Scaling Challenges Manufacturing differences between traditional mAb therapies and newer biotherapeutics dictate whether processes should be …

A Diverse Landscape of Patent Issues Seen in the US, UK, and the …
December 5, 2019 - BioPharm International A Diverse Landscape of Patent Issues Seen in the US, UK, and the EU Legal experts in biopharmaceutical patent law shed some light on trends and recent news. …

Previous PageNext Page